LRRIQ1
gene geneOn this page
Also known as FLJ12303KIAA1801
Summary
LRRIQ1 (leucine rich repeats and IQ motif containing 1, HGNC:25708) is a protein-coding gene on chromosome 12q21.31, encoding Leucine-rich repeat- and IQ domain-containing protein 1 (Q96JM4).
Predicted to be involved in regulation of signal transduction. Predicted to be active in microtubule cytoskeleton.
Source: NCBI Gene 84125 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 289 total
- MANE Select transcript:
NM_001079910
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25708 |
| Approved symbol | LRRIQ1 |
| Name | leucine rich repeats and IQ motif containing 1 |
| Location | 12q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ12303, KIAA1801 |
| Ensembl gene | ENSG00000133640 |
| Ensembl biotype | protein_coding |
| OMIM | 620922 |
| Entrez | 84125 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 5 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000393212, ENST00000393217, ENST00000525971, ENST00000526363, ENST00000528777, ENST00000529408, ENST00000533414, ENST00000602731
RefSeq mRNA: 1 — MANE Select: NM_001079910
NM_001079910
CCDS: CCDS41816
Canonical transcript exons
ENST00000393217 — 27 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001611552 | 85154012 | 85154094 |
| ENSE00001735260 | 85153024 | 85153145 |
| ENSE00001736255 | 85153663 | 85153758 |
| ENSE00001753843 | 85152280 | 85152369 |
| ENSE00001756082 | 85137850 | 85137969 |
| ENSE00001799797 | 85127832 | 85128033 |
| ENSE00002161291 | 85244789 | 85245105 |
| ENSE00002222812 | 85036351 | 85036407 |
| ENSE00002712689 | 85124070 | 85124519 |
| ENSE00003469147 | 85046020 | 85046137 |
| ENSE00003481828 | 85232696 | 85232756 |
| ENSE00003528337 | 85104004 | 85104077 |
| ENSE00003545288 | 85098867 | 85098994 |
| ENSE00003549721 | 85038153 | 85038308 |
| ENSE00003558719 | 85047247 | 85047470 |
| ENSE00003567520 | 85121697 | 85121876 |
| ENSE00003585248 | 85055547 | 85057184 |
| ENSE00003611821 | 85044718 | 85044809 |
| ENSE00003632170 | 85106522 | 85106615 |
| ENSE00003643883 | 85066748 | 85066898 |
| ENSE00003654374 | 85052177 | 85052251 |
| ENSE00003658422 | 85072907 | 85073098 |
| ENSE00003665537 | 85040490 | 85040601 |
| ENSE00003671917 | 85065262 | 85065414 |
| ENSE00003685044 | 85229517 | 85229649 |
| ENSE00003693061 | 85098355 | 85098548 |
| ENSE00003697215 | 85160613 | 85160714 |
Expression profiles
Bgee: expression breadth ubiquitous, 154 present calls, max score 93.59.
FANTOM5 (CAGE): breadth broad, TPM avg 2.2062 / max 323.2787, expressed in 531 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 127175 | 2.2062 | 531 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 93.59 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 92.07 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.93 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.60 | gold quality |
| left testis | UBERON:0004533 | 82.12 | gold quality |
| right testis | UBERON:0004534 | 81.98 | gold quality |
| bronchial epithelial cell | CL:0002328 | 81.38 | gold quality |
| testis | UBERON:0000473 | 80.13 | gold quality |
| bronchus | UBERON:0002185 | 79.55 | gold quality |
| ventricular zone | UBERON:0003053 | 76.80 | gold quality |
| cortical plate | UBERON:0005343 | 73.08 | gold quality |
| ganglionic eminence | UBERON:0004023 | 72.23 | gold quality |
| adenohypophysis | UBERON:0002196 | 71.86 | gold quality |
| metanephros cortex | UBERON:0010533 | 69.79 | gold quality |
| pituitary gland | UBERON:0000007 | 69.33 | gold quality |
| right lung | UBERON:0002167 | 68.86 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 68.67 | gold quality |
| hypothalamus | UBERON:0001898 | 68.15 | gold quality |
| fallopian tube | UBERON:0003889 | 67.89 | gold quality |
| caudate nucleus | UBERON:0001873 | 67.52 | gold quality |
| nucleus accumbens | UBERON:0001882 | 66.67 | gold quality |
| sural nerve | UBERON:0015488 | 66.24 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 65.96 | gold quality |
| pancreatic ductal cell | CL:0002079 | 65.85 | silver quality |
| thyroid gland | UBERON:0002046 | 65.80 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 64.81 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 63.99 | gold quality |
| islet of Langerhans | UBERON:0000006 | 63.89 | gold quality |
| cortex of kidney | UBERON:0001225 | 62.72 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 62.17 | gold quality |
Single-cell (SCXA)
Detected in 8 experiment(s), a significant marker in 8.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-2 | yes | 2611.96 |
| E-MTAB-10287 | yes | 768.54 |
| E-CURD-114 | yes | 718.53 |
| E-CURD-122 | yes | 704.77 |
| E-HCAD-1 | yes | 32.52 |
| E-GEOD-130148 | yes | 13.54 |
| E-MTAB-9388 | yes | 7.59 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Lrriq1 | ENSMUSG00000019892 |
Protein
Protein identifiers
Leucine-rich repeat- and IQ domain-containing protein 1 — Q96JM4 (reviewed: Q96JM4)
All UniProt accessions (6): A0A140VJN5, A0A3B3IS25, A8MY60, Q96JM4, H0YCJ9, H0YEZ5
UniProt curated annotations — full annotation on UniProt →
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96JM4-4 | 1 | yes |
| Q96JM4-2 | 2 |
RefSeq proteins (1): NP_001073379* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000048 | IQ_motif_EF-hand-BS | Binding_site |
| IPR001611 | Leu-rich_rpt | Repeat |
| IPR003591 | Leu-rich_rpt_typical-subtyp | Repeat |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR050836 | SDS22/Internalin_LRR | Family |
Pfam: PF00612, PF13855
UniProt features (27 total): repeat 10, region of interest 5, domain 4, compositionally biased region 3, sequence variant 3, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96JM4-F1 | 53.69 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 42 (showing top):
GOBP_SINGLE_FERTILIZATION, chr12q21, GOBP_FERTILIZATION, HMG20B_TARGET_GENES, HMGA1_TARGET_GENES, OVOL3_TARGET_GENES, ZNF22_TARGET_GENES, ZNF407_TARGET_GENES, MIR6083, MIR583, MIR4640_3P, MEBARKI_HCC_PROGENITOR_FZD8CRD_UP, FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON, MANNO_MIDBRAIN_NEUROTYPES_HRGL2A, MANNO_MIDBRAIN_NEUROTYPES_HRGL3
GO Biological Process (5): apoptotic process (GO:0006915), single fertilization (GO:0007338), regulation of signal transduction (GO:0009966), gene expression (GO:0010467), ectopic germ cell programmed cell death (GO:0035234)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): microtubule cytoskeleton (GO:0015630)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| programmed cell death | 1 |
| apoptotic signaling pathway | 1 |
| execution phase of apoptosis | 1 |
| fertilization | 1 |
| signal transduction | 1 |
| regulation of cell communication | 1 |
| regulation of signaling | 1 |
| regulation of response to stimulus | 1 |
| macromolecule biosynthetic process | 1 |
| developmental process involved in reproduction | 1 |
| programmed cell death involved in cell development | 1 |
| binding | 1 |
| cytoskeleton | 1 |
Protein interactions and networks
STRING
999 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| LRRIQ1 | FAM120A2P | Q5T035 | 571 |
| LRRIQ1 | TSPAN19 | P0C672 | 529 |
| LRRIQ1 | CFAP263 | Q9H0I3 | 491 |
| LRRIQ1 | FEM1B | Q9UK73 | 461 |
| LRRIQ1 | ITPRID1 | Q6ZRS4 | 461 |
| LRRIQ1 | ALX1 | Q15699 | 450 |
| LRRIQ1 | OR1J4 | Q8NGS1 | 448 |
| LRRIQ1 | CFAP52 | Q8N1V2 | 437 |
| LRRIQ1 | ZNF227 | Q86WZ6 | 431 |
| LRRIQ1 | CFAP70 | Q5T0N1 | 410 |
| LRRIQ1 | FANK1 | Q8TC84 | 405 |
| LRRIQ1 | NTS | P30990 | 398 |
| LRRIQ1 | CCT8L2 | Q96SF2 | 395 |
| LRRIQ1 | RFNG | Q9Y644 | 391 |
| LRRIQ1 | LMO2 | P25791 | 387 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRRIQ1 | TNFRSF10B | psi-mi:“MI:0914”(association) | 0.350 |
| KLHL22 | TRAV18 | psi-mi:“MI:0914”(association) | 0.350 |
| LRRIQ1 | HES4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (71): FGFR4 (Affinity Capture-MS), BMPR2 (Affinity Capture-MS), ACVR1 (Affinity Capture-MS), UNC5B (Affinity Capture-MS), FGFR2 (Affinity Capture-MS), ACVR2B (Affinity Capture-MS), PTPRS (Affinity Capture-MS), ACVR2A (Affinity Capture-MS), GTF2IRD1 (Affinity Capture-MS), BMPR1A (Affinity Capture-MS), EPHA3 (Affinity Capture-MS), NDFIP1 (Affinity Capture-MS), FYN (Affinity Capture-MS), STX10 (Affinity Capture-MS), NOTCH3 (Affinity Capture-MS)
ESM2 similar proteins: A0A0M3U1B0, A0A1L8EYB2, A0JP43, A1L2Y1, A2ARZ3, A4FU69, A4L9P8, A5WUN7, A7MC64, D3Z6S9, D3Z8E6, F5H4B4, Q06190, Q08AD1, Q0P5X1, Q0P5X5, Q16533, Q2T9M9, Q3V036, Q3ZAV0, Q497N6, Q4R6W9, Q53TS8, Q5CZC0, Q5MY90, Q5RHB5, Q5T4T6, Q5T5Y3, Q66H16, Q6NXP0, Q6Q759, Q6ZQ06, Q6ZVD7, Q86WZ0, Q8BQ48, Q8BYM7, Q8C4J0, Q8C636, Q8IWA6, Q8IYM0
Diamond homologs: Q0P5X1, Q4P5F9, Q96JM4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
289 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 247 |
| Likely benign | 21 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
5143 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:85038149:GCA:G | acceptor_gain | 1.0000 |
| 12:85038168:T:G | acceptor_gain | 1.0000 |
| 12:85038168:T:TA | acceptor_gain | 1.0000 |
| 12:85038305:TACA:T | donor_gain | 1.0000 |
| 12:85038306:ACA:A | donor_gain | 1.0000 |
| 12:85038307:CA:C | donor_gain | 1.0000 |
| 12:85038308:AG:A | donor_loss | 1.0000 |
| 12:85038309:G:GG | donor_gain | 1.0000 |
| 12:85038311:GAGTA:G | donor_loss | 1.0000 |
| 12:85040481:A:G | acceptor_gain | 1.0000 |
| 12:85040485:TTTA:T | acceptor_loss | 1.0000 |
| 12:85040486:TTA:T | acceptor_loss | 1.0000 |
| 12:85040488:A:AG | acceptor_gain | 1.0000 |
| 12:85040488:A:AT | acceptor_loss | 1.0000 |
| 12:85040489:G:GG | acceptor_gain | 1.0000 |
| 12:85040597:TTTAA:T | donor_gain | 1.0000 |
| 12:85040598:TTAA:T | donor_gain | 1.0000 |
| 12:85040599:TAA:T | donor_gain | 1.0000 |
| 12:85040600:AA:A | donor_gain | 1.0000 |
| 12:85040602:G:GG | donor_gain | 1.0000 |
| 12:85044713:TCTA:T | acceptor_loss | 1.0000 |
| 12:85044715:TA:T | acceptor_loss | 1.0000 |
| 12:85044716:A:AG | acceptor_gain | 1.0000 |
| 12:85044717:G:GG | acceptor_gain | 1.0000 |
| 12:85044717:GGCT:G | acceptor_gain | 1.0000 |
| 12:85044805:TTAAG:T | donor_loss | 1.0000 |
| 12:85044806:TAAGG:T | donor_loss | 1.0000 |
| 12:85044807:AAGG:A | donor_loss | 1.0000 |
| 12:85044808:AGG:A | donor_loss | 1.0000 |
| 12:85044809:GGTAT:G | donor_loss | 1.0000 |
AlphaMissense
11496 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:85098536:T:A | N1023K | 0.996 |
| 12:85098536:T:G | N1023K | 0.996 |
| 12:85098470:T:A | N1001K | 0.995 |
| 12:85098470:T:G | N1001K | 0.995 |
| 12:85104067:T:A | N1091K | 0.995 |
| 12:85104067:T:G | N1091K | 0.995 |
| 12:85098920:C:A | N1045K | 0.994 |
| 12:85098920:C:G | N1045K | 0.994 |
| 12:85106589:C:A | N1117K | 0.992 |
| 12:85106589:C:G | N1117K | 0.992 |
| 12:85066753:C:A | N850K | 0.991 |
| 12:85066753:C:G | N850K | 0.991 |
| 12:85066816:T:A | N871K | 0.991 |
| 12:85066816:T:G | N871K | 0.991 |
| 12:85066881:A:T | N893I | 0.991 |
| 12:85098388:T:C | L974P | 0.991 |
| 12:85098409:T:C | L981S | 0.991 |
| 12:85098469:A:T | N1001I | 0.991 |
| 12:85098992:C:A | N1069K | 0.991 |
| 12:85098992:C:G | N1069K | 0.991 |
| 12:85104051:T:C | L1086P | 0.991 |
| 12:85098404:T:A | N979K | 0.990 |
| 12:85098404:T:G | N979K | 0.990 |
| 12:85098454:T:C | L996P | 0.990 |
| 12:85098403:A:T | N979I | 0.989 |
| 12:85066882:T:A | N893K | 0.988 |
| 12:85066882:T:G | N893K | 0.988 |
| 12:85098535:A:T | N1023I | 0.988 |
| 12:85153757:T:A | W1546R | 0.988 |
| 12:85153757:T:C | W1546R | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000000145 (12:85178561 G>A), RS1000012926 (12:85055223 T>C), RS1000013502 (12:85228317 T>A), RS1000018097 (12:85105915 G>A,C), RS1000019008 (12:85149703 G>A), RS1000022955 (12:85039799 A>T), RS1000025068 (12:85047048 T>C), RS1000036598 (12:85046828 A>G), RS1000064621 (12:85134617 G>A,T), RS1000081142 (12:85234439 A>G), RS1000081320 (12:85091779 A>T), RS1000089790 (12:85041652 T>C), RS1000090568 (12:85149376 C>T), RS1000093558 (12:85036595 T>C), RS1000093951 (12:85134339 C>T)
Disease associations
OMIM: gene MIM:620922 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003654_16 | Bone mineral density (Ward’s triangle area) | 4.000000e-06 |
| GCST003996_8 | Monobrow | 1.000000e-12 |
| GCST009462_73 | Optic disc size | 1.000000e-08 |
| GCST010703_58 | Brain morphology (MOSTest) | 2.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007785 | femoral neck bone mineral density |
| EFO:0007906 | synophrys measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression, affects cotreatment, affects response to substance | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression, affects cotreatment | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.